Hormone replacement therapy - Risk for breast cancer: Current situation;Hormonersatztherapie und brustkrebsrisiko: Aktuelle situation

Journal fur Menopause

Volumn 12, Issue 1, 2005, Pages 22-24

  Luzuy, Frank ^a  

^a NONE   (Switzerland)

Author keywords

Breast cancer; Hormone replacement therapy; HRT

Indexed keywords

ANAMNESIS; BREAST CANCER; CANCER RISK; CLINICAL TRIAL; DRUG EFFECT; HORMONE SUBSTITUTION; HUMAN; META ANALYSIS; PATIENT SELECTION; PRESCRIPTION; QUALITY OF LIFE; REVIEW; RISK BENEFIT ANALYSIS; SYSTEMATIC REVIEW;

EID: 20344390548     PISSN: 10230904     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (9)

1. The Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004; 291: 1701-12.
2. Colditz GA, Rosner B. Cumulative risk of breast cancer to age 70 years according to risk factor status : data from the Nurses' Health Study. Am J Epidemiol 2000; 152: 950-64.
3. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer. Lancet 1997; 350: 1047-59.
4. Christopher IL et al. Relationship between long durations and different regimens of hormone therapy and risk of breast cancer. JAMA 2003; 289: 3254-63.
5. Dupont WD, Page DL, Parl FF, et al. Estrogen replacement therapy in women with a history of proliferative breast disease. Cancer 1999; 85: 1277-83.
6. The writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 2002; 288: 321-33.
7. Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003; 362: 419-427.
8. Smith-Warner SA, Spiegelman D, Shlow-Shyuan, et al. Alcohol and breast cancer in women. A pooled analysis of cohort studies. JAMA 1998; 279: 535-40.
9. Thomas HV, Reeves GK, Key TJ. Endogenous estrogen and postmenopausal breast cancer: A quantitative review. Cancer causes control 1997; 8: 922-8.